U.S. Demand for Disposable Medical Supplies to Reach $49.3 Billion
U.S. demand for disposable medical supplies will expand 4.1 percent annually to $49.3 billion in 2018. According to Freedonia analyst Bill Martineau, An increasing volume of patient activity attributable to an aging population, a rising incidence of medical conditions, and the extension of health insurance coverage by the Affordable Care Act of 2010 will comprise the major factors spurring growth.Â
The US disposable medical supplies market will also benefit from a heightened focus on infection prevention throughout the healthcare sector. These and other trends are presented in "Disposable Medical Supplies," a new study from The Freedonia Group, Inc., a Cleveland-based industry market research firm.
Based on an increasing number of patients who need surgery or long-term chronic care therapy, drug delivery and related products will remain the fastest expanding group of disposable medical supplies. Total demand registered by this product group will rise 5.1 percent annually to $13.4 billion in 2018. Safety-enhanced devices for the minimally invasive delivery of parenteral medicines, inhalation therapies, and IV and dialysis solutions will lead growth.
Disposable wound management products will post demand of $11.2 billion in 2018, up 3.8 percent annually from 2013. Polymeric tissue sealants, along with alginate, foam, and collagen wound dressings, will realize the fastest growth based on enhanced safety and faster healing properties. Conversely, demand for bandages will expand at a below average pace due to limited pricing flexibility and the overall lack of proprietary types. First aid kits will fare the best among other disposable wound management products, benefiting from trends promoting self-treatment.Â
Compared to disposable medical supplies as a whole, nonwoven medical disposables will see above average growth in demand. The heightened focus on infection prevention in the health care sector will boost consumption of single use, high value-added nonwoven garments and textiles by hospitals and outpatient facilities. A rising prevalence of incontinence problems attributable to the aging population will impact favorably on retail and institutional sales of nonwoven adult undergarments, shields and other protective products.
Source: The Freedonia Group, Inc.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
